NEW ORLEANS, LA—A PCSK9 inhibitor used on top of lipid-lowering therapy, including a high-intensity statin, significantly cuts the risk of major adverse cardiovascular events compared with placebo ...
The neurologist Orlando Swayne doesn’t suggest everyone can recover. But he does argue that early, targeted and intense therapy can sometimes bring about life-changing improvements – and we have a mor ...
According to reports 1, stroke was the second leading cause of death globally in 2019, which will increase the economic burden in various countries, especially in low-income countries; ischemic stroke ...
The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...
To examine heterogeneity in the impact of increased early rehabilitation intensity and to identify which ischemic stroke patients benefit most. We analysed 39,140 propensity score-matched ischemic ...
After identifying significant differences in stroke care and outcomes for patients on different Medicare plans, a UVA Health ...
Live Science on MSN
Drug-induced 'brain freeze' may help protect the brain after a stroke, early study suggests
By tamping down metabolism, a new experimental treatment that induces a hypothermia-like state may slow stroke-associated ...
A stroke happens when blood flow to part of the brain is blocked or when a blood vessel in the brain bursts. Without enough ...
Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) are at risk for recurrent stroke. Low factor XI levels are associated with a reduced risk of ischemic stroke.
New Scientist on MSN
Chilling the body with drugs could limit brain damage from stroke
Putting brain cells into a hibernation-like state via drugs that cool down core body temperature may help to preserve them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results